Rayonier
RYN · NYSE
About RYN
- Employees
- 285
- Headquarters
- Jacksonville, Florida
- Listed
- Feb 17, 1994
- Sector
- Real Estate
- Industry
- Specialized REITs
- Website
- rayonier.com
RYN key statistics
- Market cap
- 5.63B
- Price-earnings ratio
- 42.48
- Dividend yield
- 5.27%
- Average volume
- 3.86M
- Volume
- 2.70M
- Open price
- $18.81
- High today
- $19.07
- Low today
- $18.80
- 52 Week high
- $25.13
- 52 Week low
- $17.71
Rayonier (RYN) at a glance
Rayonier (RYN) last traded at $18.81, with a market cap of 5.63B, a price-to-earnings ratio of 42.48 and a dividend yield of 5.27%.
Today the stock has traded between $18.80 and $19.07. The current price is 0.1% above the day's low and 1.3% below its high.
Volume so far is 2.70M shares, below the average of 3.86M shares a day.
Over the past year Rayonier has ranged from $17.71 to $25.13, and now sits 15% of the way up that range.
Rayonier met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.10 per share against an estimate of $0.1103.
The average analyst price target is $26.52, 41.0% above the current price, from 5 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy20.0%
- Hold80.0%
- Sell0.0%
- Low
- $23.23
- Now
- $18.81
- High
- $33.60
RYN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 52.4% on average.
- Q3 FY99: reported $0.1572 per share against an estimate of $0.1572
- Q4 FY99: reported $0.2164 per share against an estimate of $0.1245
- Q1 FY00: reported $0.1958 per share against an estimate of $0.1777
- Q2 FY00: reported $0.1623 per share against an estimate of $0.1587
- Q3 FY25: reported $0.32 per share against an estimate of $0.2246
- Q4 FY25: reported $0.20 per share against an estimate of $0.1159
- Q1 FY26: reported $0.07 per share against an estimate of -$0.541
- Q2 FY26: reported $0.10 per share against an estimate of $0.1103
RYN news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Rayonier Scheduled to Release Third Quarter Earnings on November 4
- Press releaseBusiness Wire
Rayonier Releases 2025 Corporate Responsibility Report
- Press releaseBusiness Wire
Rayonier Completes Transactions to Optimize Timberland Portfolio
- Press releaseBusiness Wire
Rayonier Reports Second Quarter 2026 Results
- Press releaseBusiness Wire
Rayonier Appoints Ryan Daniels Senior Vice President, Wood Products
- Press releaseBusiness Wire
Rayonier Announces Third Quarter 2026 Dividend
- Press releaseBusiness Wire
Rayonier Scheduled to Release Second Quarter Earnings on August 5
Similar companies
Companies in the same industry as Rayonier
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.